We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Curbing Carbohydrates Reduces Liver Fat Faster Than Dieting

By HospiMedica International staff writers
Posted on 02 May 2011
Limiting carbohydrates is more effective than cutting calories in people with nonalcoholic fatty liver disease (NAFLD) who want to reduce quickly the amount of fat in their liver, according to a new study.

Researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, USA) designed a study to determine the relative effectiveness of dietary carbohydrate and calorie restriction at reducing hepatic triglycerides in subjects with NAFLD. More...
To do so, 18 subjects (5 men and 13 women) with a mean age of 45 and a body mass index (BMI) of 35 consumed a carbohydrate restricted--less than 20 g/day, the equivalent of a small banana or a half-cup of egg noodles--or calorie restricted (1,200 kcal/day - 1,500 kcal/day) diet for two weeks. Hepatic triglycerides were measured before and after intervention by magnetic resonance spectroscopy (MRS).

The results showed that the mean weight loss was similar between the groups, at around four kilograms. Hepatic triglycerides were reduced by an average 42% in subjects with NAFLD; however, reductions were significantly greater with dietary carbohydrate restriction than with calorie restriction. Dietary fat, carbohydrate, post-treatment plasma ketones, and respiratory quotient were also related to a reduction in liver triglycerides. Aminotransferase and plasma aspartate also decreased significantly with weight loss. The study was published in the May 2011 issue of the American Journal of Clinical Nutrition.

"This is not a long-term study, and I don't think that low-carb diets are fundamentally better than low-fat ones,” said lead author Jeffrey Browning, MD, an assistant professor of internal medicine at UT Southwestern. "Our approach is likely to be only of short-term benefit because at some point the benefits of weight loss alone trounce any benefits derived from manipulating dietary macronutrients such as calories and carbohydrates. Weight loss, regardless of the mechanism, is currently the most effective way to reduce liver fat.”

NAFLD is one of the causes of fatty liver changes, involving steatosis that is not a result of excessive alcohol use. It is also related to insulin resistance and the metabolic syndrome, and may respond to treatments originally developed for other insulin-resistant states, like weight loss, metformin, and thiazolidinediones. Nonalcoholic steatohepatitis (NASH) is the most extreme form of NAFLD, and is regarded as a major cause of cirrhosis of the liver of unknown cause.

Related Links:
University of Texas (UT) Southwestern Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.